Final MSN-CNL Capstone Poster PresentationAshleyKendall6
My master's clinical nurse leader capstone quality improvement project's purpose was to decrease the number of intentional poisoning patient admissions on the transitional care unit (TCU) at SSM Health Cardinal Glennon Children's Hospital. Shown here is the project poster for presentation I created in May 2021.
Dr Martin Bardsley: Use of Retrospective Matching Methods 30 June 2014Nuffield Trust
Martin Bardsley, Director of Research, Nuffield Trust explores the use of retrospective matching methods to study health services and other sectors.
Dr Martin Bardsley spoke at the Nuffield Trust event: The future of the hospital, in June 2014.
Health Datapalooza 2013: Illuminating Disease at the Speed of Light - Michael...Health Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Illuminating Disease at the Speed of Light: How Big Data Is Accelerating Biomedical Research
Convener:
Marcia A. Kean, Chairman, Strategic Initiatives, Feinstein Kean Healthcare
Moderator:
Kevin Davies, Author, “The $1,000 Genome”; Founding Editor, Nature Genetics and Bio-IT World magazine; and Vice President Business Development, American Chemical Society
Speakers:
Amy P. Abernethy, Director, Center for Learning Healthcare (CLHC), Duke Clinical Research Institute
Michael Cantor, Senior Director, Information Strategy and Analytics, World Research Development, Pfizer
Dave King, Founder, Exaptive
Robert McBurney, Chief Executive Officer, Accelerated Cure Project for Multiple Sclerosis
Dietrich Stephan, Founder and Chief Executive Officer, Silicon Valley Biosystems (SV Bio)
Until recently, biomedical research was conducted in small silos, separated by huge cultural and technical walls and inability to exchange data facilely. But the field is now exploding: massive amounts of complex, multi-dimensional clinical, imaging, and genomic data are being collected, aggregated, integrated, analyzed, and shared. The pioneers driving this digital transformation are working in novel collaborations among patients, providers, and scientists. In this session, speakers will showcase multimodal, computational, and analytic tools for biomarker discovery, patient stratification, and intelligent clinical decision solutions; high-speed genome profiling, with algorithms of individual and population profiles, for real-time molecular-based diagnoses of ‘mystery’ diseases; a point-of-care quality monitoring program used by clinicians, in which data are used for important research questions and then transitioned into clinical trials; and collection and aggregation of data and samples from patients with a neurological disease, enabling queries into markers of disease origins and discovery of new therapies.
February 9, 2018
In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best conduct clinical trials and development of vaccines in the context of an epidemic or outbreak.
At this panel discussion, two health policy experts examined the appropriate conduct of clinical trials during public health emergencies.
Learn more at: http://petrieflom.law.harvard.edu/events/details/clinical-trials-during-public-health-emergencies
Dr. Paul Sundberg - Emerging Disease Response Planning Updates, Working on Ou...John Blue
Emerging Disease Response Planning Updates, Working on Our Preparedness - Dr. Paul Sundberg, Vice President, Science and Technology, National Pork Board, from the 2015 Minnesota Pork Congress, January 21-22, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2015-minnesota-pork-congress
The Challenges of Pooling IVE estimates - Jos Nauta, AbbottDRIVE research
DRIVE annual forum 2019, Helsinki, Finland, 17th-18th September
Development of Robust and Innovative Vaccine Effectiveness
Increasing understanding of influenza vaccine effectiveness in Europe
Talk about data visualization as tool to add new value to health data, presented in the Panel: Old School Data Set, Rebooted, Repurposed and Creating Killer New Value Health Datapalooza, June 2, 2015
Final MSN-CNL Capstone Poster PresentationAshleyKendall6
My master's clinical nurse leader capstone quality improvement project's purpose was to decrease the number of intentional poisoning patient admissions on the transitional care unit (TCU) at SSM Health Cardinal Glennon Children's Hospital. Shown here is the project poster for presentation I created in May 2021.
Dr Martin Bardsley: Use of Retrospective Matching Methods 30 June 2014Nuffield Trust
Martin Bardsley, Director of Research, Nuffield Trust explores the use of retrospective matching methods to study health services and other sectors.
Dr Martin Bardsley spoke at the Nuffield Trust event: The future of the hospital, in June 2014.
Health Datapalooza 2013: Illuminating Disease at the Speed of Light - Michael...Health Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Illuminating Disease at the Speed of Light: How Big Data Is Accelerating Biomedical Research
Convener:
Marcia A. Kean, Chairman, Strategic Initiatives, Feinstein Kean Healthcare
Moderator:
Kevin Davies, Author, “The $1,000 Genome”; Founding Editor, Nature Genetics and Bio-IT World magazine; and Vice President Business Development, American Chemical Society
Speakers:
Amy P. Abernethy, Director, Center for Learning Healthcare (CLHC), Duke Clinical Research Institute
Michael Cantor, Senior Director, Information Strategy and Analytics, World Research Development, Pfizer
Dave King, Founder, Exaptive
Robert McBurney, Chief Executive Officer, Accelerated Cure Project for Multiple Sclerosis
Dietrich Stephan, Founder and Chief Executive Officer, Silicon Valley Biosystems (SV Bio)
Until recently, biomedical research was conducted in small silos, separated by huge cultural and technical walls and inability to exchange data facilely. But the field is now exploding: massive amounts of complex, multi-dimensional clinical, imaging, and genomic data are being collected, aggregated, integrated, analyzed, and shared. The pioneers driving this digital transformation are working in novel collaborations among patients, providers, and scientists. In this session, speakers will showcase multimodal, computational, and analytic tools for biomarker discovery, patient stratification, and intelligent clinical decision solutions; high-speed genome profiling, with algorithms of individual and population profiles, for real-time molecular-based diagnoses of ‘mystery’ diseases; a point-of-care quality monitoring program used by clinicians, in which data are used for important research questions and then transitioned into clinical trials; and collection and aggregation of data and samples from patients with a neurological disease, enabling queries into markers of disease origins and discovery of new therapies.
February 9, 2018
In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best conduct clinical trials and development of vaccines in the context of an epidemic or outbreak.
At this panel discussion, two health policy experts examined the appropriate conduct of clinical trials during public health emergencies.
Learn more at: http://petrieflom.law.harvard.edu/events/details/clinical-trials-during-public-health-emergencies
Dr. Paul Sundberg - Emerging Disease Response Planning Updates, Working on Ou...John Blue
Emerging Disease Response Planning Updates, Working on Our Preparedness - Dr. Paul Sundberg, Vice President, Science and Technology, National Pork Board, from the 2015 Minnesota Pork Congress, January 21-22, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2015-minnesota-pork-congress
The Challenges of Pooling IVE estimates - Jos Nauta, AbbottDRIVE research
DRIVE annual forum 2019, Helsinki, Finland, 17th-18th September
Development of Robust and Innovative Vaccine Effectiveness
Increasing understanding of influenza vaccine effectiveness in Europe
Talk about data visualization as tool to add new value to health data, presented in the Panel: Old School Data Set, Rebooted, Repurposed and Creating Killer New Value Health Datapalooza, June 2, 2015
surveillance.pptx. conceptual vice all aboutssuserf5da84
This slide is about servelince in epidiomology in this slide is to how to do servelwnce i am uploding a vary good conceptjejejdbnejdjejd ejdje ekf rjjdjejejrjrjrjife eifnje f3id 3jjr
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. Public Health Surveillance
“ The ongoing systematic collection, analysis, and interpretation of health data
essential to the planning, implementation, and evaluation of public health
practice, closely integrated with the timely dissemination of these data to
those who need to know.” -CDC
Action
-Planning,
- Implementation &
-Evaluation
Information
-Collection
-Analysis
-Interpretation
- Dissemination
3. Methodology of Surveillance
2. Active
Surveillance
1. Passive
surveillance
Integrated
surveillance
Data is collected by
Existing rules
Integrated into
Routine HC delivery
Formalized
Activated passive
surveillance- Special
efforts made to
maximize reporting
-Reminders, Visits
Actively contacting &
collecting data.
Informalized
Sentinel
Surveillance
Choosing a key
location to monitor
For a condition of
interest
Using a single infrastructure
Gathering about multiple
diseases or behaviors
To several intervention
programs
4. 1. Monitoring disease trends
2. Describing natural history of diseases
3. Identifying epidemics or new syndromes
4. Monitoring changes in infectious agents
5. Identifying areas for research
6. Evaluating hypotheses
7. Planning public health policy
8. Evaluating public health policy/interventions
9. Projecting future needs
10. Monitoring risk factors
Uses
5. Steps in Surveillance
1. Establish objectives
2. Develop case definition
3. Develop data collection source
4. Develop data collection instrument
5. Field test methods
6. Develop Analytic approach
7. Determine Information dissemination mechanism
8. Determine evaluation method
6. The dynamic vision
Reporting
Feedback
Telephone, Mail,
Web site, Epid bulletin
Evaluation
Results of action
Results of surveillance
Analysis
Data validation
Data Reliability
Descriptive analysis
Hypothesis generation
Interpretation
Disease trends
Identifying epidemics
Evaluating public policy
Future projects
Paper, Telephone, Fax
E-mail, Web based
Data
Action
Control
Preventive
Policy
Information
Organizing data
Decision
How to control
How to prevent
Policy decisions?
Active
Passive
Health care system
Public health authority
7. Methodologies
Active
Actively contacting &
collecting data.
Informalized
More consistent data
Useful for disease of importance
Motivated staff
Fast process
Expensive
Only detect targeted diseases
May not representative
Passive
Data is collected by
Existing rules
Formalized
Inexpensive
Standardized
Identifying Epidemics
Detecting emerging diseases
Under reporting
Incomplete data
Slow process
Concept
Advantages
Disadvantages
Screening